Press Releases about Acorda Therapeutics
Acorda Therapeutics Reports Third Quarter 2023 Financial Results
November 13, 2023
From Acorda Therapeutics
Via Business Wire
From Acorda Therapeutics
Via Business Wire
From Acorda Therapeutics
Via Business Wire
From Acorda Therapeutics
Via Business Wire
From Acorda Therapeutics
Via Business Wire
From Acorda Therapeutics
Via Business Wire
Acorda Therapeutics Receives Nasdaq Extension to Meet Minimum Bid Price Requirement
February 14, 2023
From Acorda Therapeutics
Via Business Wire
Acorda Therapeutics to Present at Sequire Biotechnology Conference
January 31, 2023
From Acorda Therapeutics
Via Business Wire
Acorda Therapeutics Announces Revised Long-Term Financial Guidance
December 22, 2022
From Acorda Therapeutics
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|